Law360, New York (March 30, 2009, 12:00 AM EDT) -- A federal appeals court partly affirmed and partly reversed a district court decision on Monday, upholding a permanent injunction that bars Endotec Inc. from distributing a knee joint replacement device – now approved by the FDA – and instructing the lower court to enter a new permanent injunction barring the sale without a prescription of one of Endotec's ankle devices.
(Corrects an article published on Mar. 30.)
A three-judge panel of the U.S. Court of Appeals for the Eleventh Circuit ruled in favor of the U.S....
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.